499 related articles for article (PubMed ID: 27526275)
1. Ceftaroline Plus Ampicillin Against Gram-Positive Organisms: Results from E-Test Synergy Assays.
D'Arezzo S; Mazzarelli A; Venditti C; Nisii C; Petrosillo N; De Giuli C; Vulcano A; Paglia MG; Bordi E; Di Caro A; Taglietti F
Microb Drug Resist; 2017 Jun; 23(4):507-515. PubMed ID: 27526275
[TBL] [Abstract][Full Text] [Related]
2. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
Smith JR; Yim J; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2016 Apr; 60(4):2352-8. PubMed ID: 26833159
[TBL] [Abstract][Full Text] [Related]
3. In vitro efficacy of fosfomycin-based combinations against clinical vancomycin-resistant Enterococcus isolates.
Tang HJ; Chen CC; Zhang CC; Su BA; Li CM; Weng TC; Chiang SR; Ko WC; Chuang YC
Diagn Microbiol Infect Dis; 2013 Nov; 77(3):254-7. PubMed ID: 24029433
[TBL] [Abstract][Full Text] [Related]
4. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics of Ceftaroline plus Ampicillin against Enterococcus faecalis in an
Werth BJ; Shireman LM
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096164
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic resistant fecal isolates of Enterococci among unselected patients outside the clinical sector: an epidemiological study from Southern Germany.
Lietzau S; Hoewner M; von Baum H; Marre R; Brenner H
Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):275-7. PubMed ID: 16287198
[TBL] [Abstract][Full Text] [Related]
7. In vitro synergism and anti-biofilm activity of ampicillin, gentamicin, ceftaroline and ceftriaxone against Enterococcus faecalis.
Thieme L; Klinger-Strobel M; Hartung A; Stein C; Makarewicz O; Pletz MW
J Antimicrob Chemother; 2018 Jun; 73(6):1553-1561. PubMed ID: 29506271
[TBL] [Abstract][Full Text] [Related]
8.
Brown Gandt A; Griffith EC; Lister IM; Billings LL; Han A; Tangallapally R; Zhao Y; Singh AP; Lee RE; LaFleur MD
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29784838
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010).
Sader HS; Moet GJ; Farrell DJ; Jones RN
Diagn Microbiol Infect Dis; 2011 Jul; 70(3):412-6. PubMed ID: 21546202
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibilities of enterococcal blood culture isolates from the Hamburg area to ten antibiotics.
Elsner HA; Sobottka I; Feucht HH; Claussen M; Kaulfers PM; Laufs R; Mack D
Chemotherapy; 2000; 46(2):104-10. PubMed ID: 10671760
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009.
Dowzicky MJ
Clin Ther; 2011 Dec; 33(12):1964-73. PubMed ID: 22078154
[TBL] [Abstract][Full Text] [Related]
12. Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium.
Aligholi M; Emaneini M; Taherikalani M; Shahsavan S; Jabalameli F; Asadollahi P; Khoramian B; Eslampour MA
Acta Microbiol Immunol Hung; 2011 Sep; 58(3):219-26. PubMed ID: 21983323
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial resistance profile of Enterococcus species isolated from intestinal tracts of hospitalized patients in Jimma, Ethiopia.
Abamecha A; Wondafrash B; Abdissa A
BMC Res Notes; 2015 Jun; 8():213. PubMed ID: 26036911
[TBL] [Abstract][Full Text] [Related]
14. β-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.
Smith JR; Barber KE; Raut A; Aboutaleb M; Sakoulas G; Rybak MJ
J Antimicrob Chemother; 2015; 70(6):1738-43. PubMed ID: 25645208
[TBL] [Abstract][Full Text] [Related]
15. The combination of ampicillin plus ceftaroline is synergistic against Enterococcus faecalis.
Werth BJ; Abbott AN
J Antimicrob Chemother; 2015 Aug; 70(8):2414-7. PubMed ID: 25953804
[No Abstract] [Full Text] [Related]
16. In vitro activity of RPR 106972 alone and in combination with vancomycin, ampicillin, and gentamicin against multidrug-resistant enterococci.
Messick CR; Woodward J; Pendland SL
Diagn Microbiol Infect Dis; 1998 Oct; 32(2):95-9. PubMed ID: 9823531
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of ampicillin and ceftriaxone against ampicillin-susceptible Enterococcus faecium.
Lorenzo MP; Kidd JM; Jenkins SG; Nicolau DP; Housman ST
J Antimicrob Chemother; 2019 Aug; 74(8):2269-2273. PubMed ID: 31050740
[TBL] [Abstract][Full Text] [Related]
18. 1,2,4-Oxadiazole antimicrobials act synergistically with daptomycin and display rapid kill kinetics against MDR Enterococcus faecium.
Carter GP; Harjani JR; Li L; Pitcher NP; Nong Y; Riley TV; Williamson DA; Stinear TP; Baell JB; Howden BP
J Antimicrob Chemother; 2018 Jun; 73(6):1562-1569. PubMed ID: 29518208
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of Vancomycin-Resistant Enterococcus Strains in the West Balkans: A First Report.
Jakovac S; Bojić EF; Ibrišimović MA; Tutiš B; Ostojić M; Hukić M
Microb Drug Resist; 2017 Jan; 23(1):122-126. PubMed ID: 27351410
[TBL] [Abstract][Full Text] [Related]
20. Surveillance of gram-positive cocci infections and drug resistance.
Li G; Hou S; Li Y; Liu S; Teng D; Hou D
Cell Mol Biol (Noisy-le-grand); 2015 Sep; 61(4):90-3. PubMed ID: 26386666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]